ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 83 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22,873 | -24.2% | 70,163 | -0.0% | 0.00% | – |
| Q1 2023 | $30,173 | -19.9% | 70,170 | -1.3% | 0.00% | – |
| Q4 2022 | $37,667 | -58.1% | 71,070 | -42.1% | 0.00% | – |
| Q3 2022 | $90,000 | -59.3% | 122,662 | +13.8% | 0.00% | -100.0% |
| Q1 2022 | $221,000 | +194.7% | 107,747 | +312.9% | 0.00% | – |
| Q4 2021 | $75,000 | -90.7% | 26,096 | -86.3% | 0.00% | -100.0% |
| Q3 2021 | $807,000 | +133.2% | 190,430 | +190.8% | 0.00% | +100.0% |
| Q2 2021 | $346,000 | +16.9% | 65,476 | +2.7% | 0.00% | 0.0% |
| Q1 2021 | $296,000 | -29.5% | 63,746 | -8.4% | 0.00% | 0.0% |
| Q4 2019 | $420,000 | +250.0% | 69,563 | +72.0% | 0.00% | – |
| Q4 2018 | $120,000 | -14.3% | 40,447 | +172.4% | 0.00% | -100.0% |
| Q1 2016 | $140,000 | – | 14,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |